Hereditary Cancer Testing

Genetic testing yields a wealth of information about your risk for developing hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancers. With 5-10% of all cancer estimated to be hereditary, more and more Canadians with early cancer diagnoses or family histories of cancer are considering genetic testing from LifeLabs, so they can learn more about their risks ahead of time.

Colorectal Health (FIT) Kit

The Colorectal Health (FIT) kit can help optimize your colorectal health by screening for colorectal cancer and pre-cancerous growths.

Prostate-Specific Antigen (PSA) Test

One in nine men in Canada will be diagnosed with prostate cancer in their lifetime. Prostate cancer is highly treatable if diagnosed in the early stages. A PSA test from LifeLabs measures your prostate-specific antigen (PSA) levels and can aide in early detection of the disease.

Signatera

Signatera is a genetics-based cancer test (molecular residual disease test - MRD). It is personalized to detect and monitor your cancer status by examining your unique tumour mutation profile. It can do this much sooner and more accurately compared to traditional diagnostic methods (e.g. imaging).

Cervical Health (HPV) Kit

Testing for high-risk HPV types is an important step in detecting cervical cancer early.